Mendelics Análise Genômica
PrivateLast Round
Debt
Apr 10, 2026
Est. Valuation
$120.31M
Total Funding Raised
$22.33M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Mendelics Análise Genômica operates in Healthcare & Life Sciences and is based in São Paulo. Its latest recorded funding round was a Series B Extension round in October 2023.
Mendelics Análise Genômica is a biotechnology company that provides genomic diagnostic services for rare diseases and cancer using next-generation sequencing technology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Medical AI, Healthcare Analytics
Business Model
B2B
Customer Profile
Usage-Based SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Mendelics Análise Genômica Comparables
Compare Mendelics Análise Genômica with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| NeoGenômica | 80% | |
| CENTOGENE | 78% | |
| Aegicare (Shenzhen) Technology Co., Ltd. | 78% |
For institutional investors. Book with your work email.
Mendelics Análise Genômica Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Apr 10, 2026 | ||||
| Series B Extension | Oct 19, 2023 | ||||
| Series B | Nov 26, 2019 | ||||
| Series A | Dec 1, 2014 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Mendelics Análise Genômica Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Bank for Economic and Social Development | Debt |
| FinHealth Gestão de Recursos | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 10, 2026
$9.55M debt round led by National Bank for Economic and Social Development.
For institutional investors. Book with your work email.
Mendelics Análise Genômica Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Mendelics Análise Genômica's valuation, stock price, and market status.
Is Mendelics Análise Genômica a public or private company?
Mendelics Análise Genômica is a private company.
What is the current stock price of Mendelics Análise Genômica?
Mendelics Análise Genômica is a private company, so its shares have no public market price. Caplight tracks Mendelics Análise Genômica's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Mendelics Análise Genômica worth (valuation)?
Mendelics Análise Genômica's valuation is estimated at $120.3M based on funding round data.
Can I buy Mendelics Análise Genômica stock?
Mendelics Análise Genômica shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Mendelics Análise Genômica's last funding round?
Mendelics Análise Genômica's most recent funding round was Debt on April 10, 2026.
Who are the main investors in Mendelics Análise Genômica?
Key investors in Mendelics Análise Genômica include National Bank for Economic and Social Development, FinHealth Gestão de Recursos.
Will Mendelics Análise Genômica IPO soon?
No public IPO plans have been announced for Mendelics Análise Genômica.
How can I track Mendelics Análise Genômica secondary market activity?
Caplight tracks bids, offers, and trades in Mendelics Análise Genômica's shares on secondary markets.